RUO IVD Products: Why the Label Alone Does Not Set Intended Use
A research-use-only statement must be consistent with the manufacturer’s intended use. FDA’s RUO/IUO guidance looks beyond the presence of a…
Category
A research-use-only statement must be consistent with the manufacturer’s intended use. FDA’s RUO/IUO guidance looks beyond the presence of a…
IVD labeling requirements include a lot or control number traceable to production history. A readiness review should test the connection…
Reprocessing is not a routine way to release a nonconforming supplement. Part 111 requires material review, a documented disposition decision,…
Part 111 requires reserve samples from each distributed lot of packaged and labeled dietary supplements. The quantity and retention rules…
A supplier certificate of analysis does not automatically replace dietary-ingredient identity testing. Part 111 treats identity verification and permitted CoA…
FDA does not prescribe one universal test list for cosmetic safety substantiation. The responsible person still needs adequate supporting safety…
Cosmetic adverse-event records generally have a six-year retention period. A qualifying small responsible person may have a three-year period under…
Under MoCRA, the responsible person is identified through the cosmetic label. Using a contract manufacturer does not, by itself, make…
Discover how a virtual FDA mock inspection stress-tests your quality systems without disrupting active production schedules. As federal regulators expand…
Prepare your wellness brand for an FDA nutraceutical inspection under 21 CFR Part 111. While the commercial market uses the…
Sign in to access member resources, inspection tools and training.
New here? Create an account
Set up an account to access member resources, inspection tools and training.
Already have an account? Log in
Enter your username or email and we will send you a link to set a new password.
Remembered it? Log in